Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9-12 years) and adolescents.
El-Araby, Hanaa A
Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9-12 years) and adolescents. [electronic resource] - Hepatology international Nov 2019 - 706-714 p. digital
Publication Type: Journal Article; Observational Study
1936-0541
10.1007/s12072-019-09985-w doi
Administration, Oral
Adolescent
Adolescent Health Services
Antiviral Agents--administration & dosage
Benzimidazoles--administration & dosage
Child
Child Health Services
Drug Administration Schedule
Egypt
Female
Fluorenes--administration & dosage
Genotype
Hepatitis C, Chronic--drug therapy
Humans
Male
Prospective Studies
Sofosbuvir
Treatment Outcome
Uridine Monophosphate--administration & dosage
Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9-12 years) and adolescents. [electronic resource] - Hepatology international Nov 2019 - 706-714 p. digital
Publication Type: Journal Article; Observational Study
1936-0541
10.1007/s12072-019-09985-w doi
Administration, Oral
Adolescent
Adolescent Health Services
Antiviral Agents--administration & dosage
Benzimidazoles--administration & dosage
Child
Child Health Services
Drug Administration Schedule
Egypt
Female
Fluorenes--administration & dosage
Genotype
Hepatitis C, Chronic--drug therapy
Humans
Male
Prospective Studies
Sofosbuvir
Treatment Outcome
Uridine Monophosphate--administration & dosage